184 related articles for article (PubMed ID: 10820269)
1. Secreted and membrane-associated matrix metalloproteinases of IL-2-activated NK cells and their inhibitors.
Kim MH; Kitson RP; Albertsson P; Nannmark U; Basse PH; Kuppen PJ; Hokland ME; Goldfarb RH
J Immunol; 2000 Jun; 164(11):5883-9. PubMed ID: 10820269
[TBL] [Abstract][Full Text] [Related]
2. Expression of matrix metalloproteinases and their inhibitors by rat NK cells: inhibition of their expression by genistein.
Kim MH; Albertsson P; Xue Y; Kitson RP; Nannmark U; Goldfarb RH
In Vivo; 2000; 14(5):557-64. PubMed ID: 11125539
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases produced by rat IL-2-activated NK cells.
Kitson RP; Appasamy PM; Nannmark U; Albertsson P; Gabauer MK; Goldfarb RH
J Immunol; 1998 May; 160(9):4248-53. PubMed ID: 9574526
[TBL] [Abstract][Full Text] [Related]
4. Rat pancreatic stellate cells secrete matrix metalloproteinases: implications for extracellular matrix turnover.
Phillips PA; McCarroll JA; Park S; Wu MJ; Pirola R; Korsten M; Wilson JS; Apte MV
Gut; 2003 Feb; 52(2):275-82. PubMed ID: 12524413
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinases of human NK cells.
Albertsson P; Kim MH; Jonges LE; Kitson RP; Kuppen PJ; Johansson BR; Nannmark U; Goldfarb RH
In Vivo; 2000; 14(1):269-76. PubMed ID: 10757086
[TBL] [Abstract][Full Text] [Related]
6. The role of IL-18 in the modulation of matrix metalloproteinases and migration of human natural killer (NK) cells.
Ishida Y; Migita K; Izumi Y; Nakao K; Ida H; Kawakami A; Abiru S; Ishibashi H; Eguchi K; Ishii N
FEBS Lett; 2004 Jul; 569(1-3):156-60. PubMed ID: 15225625
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases and their tissue inhibitors in the developing neonatal mouse uterus.
Hu J; Zhang X; Nothnick WB; Spencer TE
Biol Reprod; 2004 Nov; 71(5):1598-604. PubMed ID: 15240428
[TBL] [Abstract][Full Text] [Related]
8. Upregulated expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in BALB/c mouse brain challenged with Japanese encephalitis virus.
Shukla V; Kumar Shakya A; Dhole TN; Misra UK
Neuroimmunomodulation; 2012; 19(4):241-54. PubMed ID: 22441541
[TBL] [Abstract][Full Text] [Related]
9. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
10. Evidence for a role of matrix metalloproteinases and their inhibitors in primordial germ cell migration.
Díez-Torre A; Díaz-Núñez M; Eguizábal C; Silván U; Aréchaga J
Andrology; 2013 Sep; 1(5):779-86. PubMed ID: 23843195
[TBL] [Abstract][Full Text] [Related]
11. Modulation of matrix metalloproteinase and TIMP-1 expression by cytokines in human RPE cells.
Eichler W; Friedrichs U; Thies A; Tratz C; Wiedemann P
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2767-73. PubMed ID: 12147614
[TBL] [Abstract][Full Text] [Related]
12. Characterization of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in prostate cancer cell lines.
Daja MM; Niu X; Zhao Z; Brown JM; Russell PJ
Prostate Cancer Prostatic Dis; 2003; 6(1):15-26. PubMed ID: 12664060
[TBL] [Abstract][Full Text] [Related]
13. Production of matrix metalloproteinases in human cultured mast cells: involvement of protein kinase C-mitogen activated protein kinase kinase-extracellular signal-regulated kinase pathway.
Kimata M; Ishizaki M; Tanaka H; Nagai H; Inagaki N
Allergol Int; 2006 Mar; 55(1):67-76. PubMed ID: 17075289
[TBL] [Abstract][Full Text] [Related]
14. ERK1/2 and p38 MAP kinase control MMP-2, MT1-MMP, and TIMP action and affect cell migration: a comparison between mesothelioma and mesothelial cells.
Zhong J; Gencay MM; Bubendorf L; Burgess JK; Parson H; Robinson BW; Tamm M; Black JL; Roth M
J Cell Physiol; 2006 May; 207(2):540-52. PubMed ID: 16447244
[TBL] [Abstract][Full Text] [Related]
15. MMP and TIMP expression in quiescent, dividing, and differentiating human lens cells.
Hodgkinson LM; Duncan G; Wang L; Pennington CJ; Edwards DR; Wormstone IM
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4192-9. PubMed ID: 17724206
[TBL] [Abstract][Full Text] [Related]
16. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
Hofmann UB; Westphal JR; Waas ET; Zendman AJ; Cornelissen IM; Ruiter DJ; van Muijen GN
Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745
[TBL] [Abstract][Full Text] [Related]
18. mRNA levels of membrane-type 1 matrix metalloproteinase (MT1-MMP), MMP-2, and MMP-9 and of their inhibitors TIMP-2 and TIMP-3 in normal thyrocytes and thyroid carcinoma cell lines.
Hofmann A; Laue S; Rost AK; Scherbaum WA; Aust G
Thyroid; 1998 Mar; 8(3):203-14. PubMed ID: 9545106
[TBL] [Abstract][Full Text] [Related]
19. Characterization of matrix metalloproteinase expressed by human embryonic kidney cells.
Liu CH; Wu PS
Biotechnol Lett; 2006 Nov; 28(21):1725-30. PubMed ID: 17001501
[TBL] [Abstract][Full Text] [Related]
20. Specific expression of matrix metalloproteinases 1, 3, 9 and 13 associated with invasiveness of breast cancer cells in vitro.
Balduyck M; Zerimech F; Gouyer V; Lemaire R; Hemon B; Grard G; Thiebaut C; Lemaire V; Dacquembronne E; Duhem T; Lebrun A; Dejonghe MJ; Huet G
Clin Exp Metastasis; 2000; 18(2):171-8. PubMed ID: 11235993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
